References
- Dutch cancer figures. [cited 2012 Sep 24]. Available from: http://www.cijfersoverkanker.nl
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002.JAMA 2006;295:2164–7.
- Davies L, Welch HG. Thyroid cancer survival in the United States: Observational data from 1973 to 2005.Arch Otolaryngol Head Neck Surg 2010;136:440–4.
- Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol 2010;21(Suppl 5): v214–9.
- Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.Am J Med 1994;97:418–28.
- Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Health-related quality of life among thyroid cancer survivors: A systematic review.Clin Endocrinol (Oxf) 2011;75:544–54.
- Husson O, Haak HR, Mols F, Nieuwenhuijzen GAP, Nieuwlaat WA, Reemst PH, . Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.Acta Oncol Epub2012 Sep 27.
- Janssen-Heijnen MLG, Louwman WJ, Van de Poll-Franse LV, Coebergh JWW. Results of 50 years cancer registry in the South of the Netherlands: 1955–2004 (in Dutch). Eindhoven: Eindhoven Cancer Registry; 2005.
- van de Poll-Franse LV, Horevoorts N, Eenbergen MV, Denollet J, Roukema JA, Aaronson NK, . The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts.Eur J Cancer 2011;47:2188–94.
- Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: A new method to assess comorbidity for clinical and health services research.Arthritis Rheum 2003;49:156–63.
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.J Natl Cancer Inst 1993;85:365–76.
- van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, . Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.Eur J Cancer 2011;47:667–75.
- Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.J Clin Oncol 2011; 29:89–96.
- Shah MD, Witterick IJ, Eski SJ, Pinto R, Freeman JL. Quality of life in patients undergoing thyroid surgery.J Otolaryngol 2006;35:209–15.
- Almeida JP, Vartanian JG, Kowalski LP. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.Arch Otolaryngol Head Neck Surg 2009;135: 342–6.
- Brown RL, de Souza JA, Cohen EE. Thyroid cancer: Burden of illness and management of disease.J Cancer 2011;2: 193–9.
- Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: A clue to the understanding of subclinical thyroid disease.J Clin Endocrinol Metab 2002;87:1068–72.
- Eustatia-Rutten CF, Corssmit EP, Heemstra KA, Smit JW, Schoemaker RC, Romijn JA, . Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism.J Clin Endocrinol Metab 2008;93:2835–41.
- Utiger RD. Subclinical hyperthyroidism – just a low serum thyrotropin concentration, or something more?N Engl J Med 1994;331:1302–3.
- Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study.Lancet 2001;358:861–5.
- Kuijpens JL, Janssen-Heijnen ML, Lemmens VE, Haak HR, Heijckmann AC, Coebergh JW. Comorbidity in newly diagnosed thyroid cancer patients: A population-based study on prevalence and the impact on treatment and survival.Clin Endocrinol (Oxf) 2006;64:450–5.
- Hirsch D, Ginat M, Levy S, Benbassat C, Weinstein R, Tsvetov G, . Illness perception in patients with differentiated epithelial cell thyroid cancer.Thyroid 2009;19: 459–65.
- Schultz PN, Stava C, Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer.Head Neck 2003;25:349–56.
- Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables.Clin Oncol (R Coll Radiol) 2010;22: 395–404.
- Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, . The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: A qualitative study.PLoS One 2009;4: e4191.